TY - JOUR
T1 - Liposomes Loaded with Amaranth Unsaponifiable Matter and Soybean Lunasin Prevented Melanoma Tumor Development Overexpressing Caspase-3 in an In Vivo Model
AU - Castañeda-Reyes, Erick Damian
AU - Perea-Flores, María de Jesús
AU - Dávila-Ortiz, Gloria
AU - Gonzalez de Mejia, Elvira
N1 - USDA National Institute of Food and Agriculture 1014457. SIP Project 20220524, IPN.
We thank Karen Doty, Katherine Janssen, Susie Lin, Olivia Swanson, Carlos Ignacio Juárez Palomo, Casey Radlowsky, and Sierra Coyne for their technical assistance in the study. To Consejo Nacional de Ciencia y Tecnología (CONACyT), México, and BEIFI program from IPN for the scholarship to Erick Damián Castañeda Reyes.
PY - 2022/10
Y1 - 2022/10
N2 - The objective of this study was to assess the effectiveness of liposomes loaded with soybean lunasin and amaranth unsaponifiable matter (UM + LunLip) as a source of squalene in the prevention of melanoma skin cancer in an allograft mice model. Tumors were induced by transplanting melanoma B16-F10 cells into the mice. The most effective treatments were those including UM + LunLip, with no difference between the lunasin concentrations (15 or 30 mg/kg body weight); however, these treatments were statistically different from the tumor-bearing untreated control (G3) (p < 0.05). The groups treated with topical application showed significant inhibition (68%, p < 0.05) compared to G3. The groups treated with subcutaneous injections showed significant inhibition (up to 99%, p < 0.05) in G3. During tumor development, UM + LunLip treatments under-expressed Ki-67 (0.2-fold compared to G3), glycogen synthase kinase-3β (0.1-fold compared to G3), and overexpressed caspase-3 (30-fold compared to G3). In addition, larger tumors showed larger necrotic areas (38% with respect to the total tumor) (p < 0.0001). In conclusion, the UM + LunLip treatment was effective when applied either subcutaneously or topically in the melanoma tumor-developing groups, as it slowed down cell proliferation and activated apoptosis.
AB - The objective of this study was to assess the effectiveness of liposomes loaded with soybean lunasin and amaranth unsaponifiable matter (UM + LunLip) as a source of squalene in the prevention of melanoma skin cancer in an allograft mice model. Tumors were induced by transplanting melanoma B16-F10 cells into the mice. The most effective treatments were those including UM + LunLip, with no difference between the lunasin concentrations (15 or 30 mg/kg body weight); however, these treatments were statistically different from the tumor-bearing untreated control (G3) (p < 0.05). The groups treated with topical application showed significant inhibition (68%, p < 0.05) compared to G3. The groups treated with subcutaneous injections showed significant inhibition (up to 99%, p < 0.05) in G3. During tumor development, UM + LunLip treatments under-expressed Ki-67 (0.2-fold compared to G3), glycogen synthase kinase-3β (0.1-fold compared to G3), and overexpressed caspase-3 (30-fold compared to G3). In addition, larger tumors showed larger necrotic areas (38% with respect to the total tumor) (p < 0.0001). In conclusion, the UM + LunLip treatment was effective when applied either subcutaneously or topically in the melanoma tumor-developing groups, as it slowed down cell proliferation and activated apoptosis.
KW - C57BL/6 mice
KW - in vivo model
KW - liposomes
KW - melanoma
KW - soybean lunasin
KW - squalene from amaranth (Amaranthus hypochondriacus)
UR - http://www.scopus.com/inward/record.url?scp=85140995527&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140995527&partnerID=8YFLogxK
U2 - 10.3390/pharmaceutics14102214
DO - 10.3390/pharmaceutics14102214
M3 - Article
C2 - 36297649
AN - SCOPUS:85140995527
SN - 1999-4923
VL - 14
JO - Pharmaceutics
JF - Pharmaceutics
IS - 10
M1 - 2214
ER -